🇺🇸 FDA
Patent

US 11505601

Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum

granted A61KA61K39/395A61K39/3955

Quick answer

US patent 11505601 (Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum) held by Nanjing Legend Biotech Co., Ltd expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K39/395, A61K39/3955, A61K47/6811, A61K47/6813